selected publications
-
academic article
-
A transcriptome-wide association study among 97,898 women to identify candidate susceptibility genes for epithelial ovarian cancer risk.
Cancer Research.
78.
2018
Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.
British Journal of Cancer.
118.
2018
Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study.
International Journal of Epidemiology.
47.
2018
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Human Mutation.
39.
2018
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Mayo Clinic Proceedings.
93.
2018
Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence..
American Journal of Epidemiology.
187.
2018
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.
PLoS ONE.
13.
2018
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.
International Journal of Molecular Sciences.
19.
2018
Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.
International Journal of Cancer.
140.
2017
Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
JAMA Oncology.
3.
2017
Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.
British Journal of Cancer.
116.
2017
History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium.
Cancer Epidemiology Biomarkers & Prevention.
26.
2017
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Nature Genetics.
49.
2017
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
Clinical Cancer Research.
23.
2017
No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival.
Cancer Epidemiology Biomarkers & Prevention.
26.
2017
Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium.
British Journal of Cancer.
116.
2017
A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
International Journal of Cancer.
139.
2016
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study.
International Journal of Epidemiology.
45.
2016
Assessing the genetic architecture of epithelial ovarian cancer histological subtypes.
Human Genetics.
135.
2016
Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.
Cancer Epidemiology Biomarkers & Prevention.
25.
2016
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.
Oncotarget.
7.
2016
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.
Obstetrics and Gynecology.
127.
2016
Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.
International Journal of Epidemiology.
45.
2016
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Journal of the National Cancer Institute.
108.
2016
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk..
Human Molecular Genetics.
25.
2016
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
PLoS ONE.
11.
2016
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus.
Nature Communications.
7.
2016
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
Cancer Discovery.
6.
2016
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Breast Cancer Research.
18.
2016
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.
Breast Cancer Research.
18.
2016
Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration.
Oncotarget.
5.
2016
Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.
Cancer Epidemiology Biomarkers & Prevention.
25.
2016
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Breast Cancer Research.
18.
2016
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Gynecologic Oncology.
141.
2016
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Journal of Medical Genetics.
53.
2016
The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies.
Cancer Epidemiology.
41.
2016
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.
Breast Cancer Research.
17.
2015
Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.
Nature Communications.
6.
2015
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
PLoS ONE.
10.
2015
Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).
Journal of Genetics and Genome Research.
2.
2015
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population.
Journal of Clinical Oncology.
33.
2015
Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.
Genetic Epidemiology.
39.
2015
Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study.
Gynecologic Oncology.
136.
2015
Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium.
Clinical Cancer Research.
21.
2015
Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer.
Clinical Cancer Research.
21.
2015
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Nature Genetics.
47.
2015
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.
Cancer Epidemiology Biomarkers & Prevention.
24.
2015
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Human Molecular Genetics.
24.
2015
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Research.
16.
2014
Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
Molecular Nutrition & Food Research.
58.
2014
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.
British Journal of Cancer.
111.
2014
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Human Genetics.
133.
2014
Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome.
Cancer Immunology Research.
2.
2014
Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10.
Cancer Research.
74.
2014
Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer.
Cancer Epidemiology Biomarkers & Prevention.
23.
2014
-
dataset
-
Association of variants in small GTPase genes with epithelial ovarian cancer risk (p-value<10−4) and functional annotation..
public-library-of-science.
2018
Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility.
public-library-of-science.
2018
Associations between selected SNPs from 9p22.2 and ovarian cancer in BRCA1, BRCA2 and combined analysis of BRCA1/2 mutation carriers..
public-library-of-science.
2016
Conditional associations for BRCA1 and BRCA2 top SNPs..
public-library-of-science.
2016
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
public-library-of-science.
2016
Pairwise correlations (r2) between selected SNPs..
public-library-of-science.
2016
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk.
public-library-of-science.
2015
The most significant SNPs in the transport pathway genes and risk of EOC by histology, invasiveness, and race/ethnicity1..
public-library-of-science.
2015
Top SNPs associated with SER EOC across racial groups..
public-library-of-science.
2015
-
hide from search
-
Analysis of associations with breast and ovarian cancer risk simultaneously (competing risks analysis) for SNPs found to be associated with breast or ovarian cancer..
public-library-of-science.
2013
Associations with SNPs at the novel 17q21 region with ovarian cancer risk for BRCA1 and BRCA2 mutation carriers..
public-library-of-science.
2013
Associations with breast and ovarian cancer risk for SNPs found to be associated with risk at all 3 stages of the experiment..
public-library-of-science.
2013
Associations with breast or ovarian cancer risk for loci previously reported to be associated with cancer risk for BRCA1 mutation carriers..
public-library-of-science.
2013
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
public-library-of-science.
2013
Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome.
Cancer Epidemiology Biomarkers & Prevention.
2013
COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration.
Breast Cancer Research.
2013
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies.
Cancer Causes & Control.
2013
Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer.
Cancer Epidemiology Biomarkers & Prevention.
2013
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
Nature Communications.
2013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.
Nature Genetics.
2013
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk.
PLOS Genetics.
2013
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
The Lancet Oncology.
2013
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Nature Communications.
2013
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.
Nature Genetics.
2013
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.
Endocrine Related Cancer.
2013
DistributionA of selected
characteristics between cases and controls..
public-library-of-science.
2011
Odds ratios (OR) and 95% confidence intervals (CI)A between variants in
DCN and LUM genes and serous
epithelial ovarian cancer risk..
public-library-of-science.
2011
Per-allele odds ratios (OR) and 95% confidence intervals (CI) at
DCN rs3138165 with serous epithelial ovarian cancer
across strata of risk factors..
public-library-of-science.
2011
Polymorphisms in Stromal Genes and Susceptibility to Serous
Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association
Consortium.
public-library-of-science.
2011
Combined discovery and replication analysis: risk estimates for TERT rs7726159 for all races according to tumor behaviour and histological subtypes..
public-library-of-science.
2010
Combined discovery and replication analysis: site-specific and combined risk estimates for serous ovarian cancer for TERT rs7726159 among non-Hispanic whites..
public-library-of-science.
2010
Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer.
public-library-of-science.
2010
Description of affected and unaffected carriers selected for BRCA2 GWAS Stage 1 and 2..
public-library-of-science.
2010
Discovery analysis: risk estimates for serous ovarian cancer for three SNPs selected for replication by 16 OCAC studies..
public-library-of-science.
2010
Estimates of breast cancer association for loci (two confirmatory loci at FGFR2 and TOX3, and two novel loci with stage 1 and 2 combined of p<10−4) among BRCA2 mutation carriers in a two-staged genome-wide association study..
public-library-of-science.
2010
Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot”.
public-library-of-science.
2010
Replication analysis: risk estimates for serous invasive ovarian cancer in non-Hispanic whites for SNPs selected for replication by indicated OCAC sites..
public-library-of-science.
2010
AML experiment-wise test results for genotyping groups..
public-library-of-science.
2009
All 22 SNPs with significant associations identified using the trend test for association..
public-library-of-science.
2009
Association between Common Germline Genetic Variation in 94 Candidate Genes or Regions and Risks of Invasive Epithelial Ovarian Cancer.
public-library-of-science.
2009